ABSTRACT: Cystic fibrosis lung disease typically has a course of exacerbations and remissions, suggesting that external factors like viral infections can influence this course. Clinical data suggest synergism between respiratory syncytial virus (RSV) infections and Pseudomonas aeruginosa in cystic fibrosis (CF) lung disease. We studied the influence of RSV infection on adherence of P. aeruginosa to IB3-1, HEp-2, and A549 epithelial cell monolayers in vitro. RSV infection of epithelial cells as well as simultaneous addition of RSV and P. aeruginosa to noninfected cells both strongly enhanced the pseudomonal adherence to epithelial cells. The increased adherence varied from 1.2-to 8.2-fold in case of previous RSV infection, and from 1.7-to 16.1-fold in case of simultaneous addition. We observed direct binding of RSV to P. aeruginosa, and blocking of RSV with heparin eliminated the effect on increased adherence. This suggests that RSV possibly acts as a coupling agent between P. aeruginosa and epithelial cells. 
C
F is characterized by chronic inflammation, bacterial colonization, and recurrent infections of the lung, which results in irreversible deterioration of lung function and early death. Pseudomonas aeruginosa is one of the most important bacterial pathogens in CF. Chronic infection of the airways with P. aeruginosa accelerates the progression to irreversible lung damage (1) . Impaired mucociliary transport and antipseudomonal defense, specific binding to asialoGM-1 receptors, and persistent inflammation probably play a role in chronic pseudomonal colonization in CF patients (2) . Besides a constitutive inflammatory state, CF lung disease typically has a course of exacerbations and remissions. This suggests that external factors influence this course, e.g. viral infections. Although the prevalence of viral infections seems to be equal in CF patients and healthy controls (3, 4) , CF patients are more likely to develop a lower respiratory tract infection with more and prolonged symptoms (3, 5, 6) . The mechanisms behind these differences are not elucidated.
Synergism between viruses and bacteria in inducing infections of respiratory epithelium has been described both in vitro (7) (8) (9) and in vivo (10, 11) . Circumstantial evidence suggests that initial pseudomonal colonization and persistent infection in CF might be facilitated by respiratory viral infections, especially by RSV (12) (13) (14) . We speculate that synergism between respiratory viral infections and pseudomonal colonization plays an important role in the pathogenesis of CF pulmonary disease. Therefore, we studied whether RSV infection enhances the adherence of P. aeruginosa to human respiratory epithelial cells and we tried to elucidate some of the underlying mechanism.
MATERIALS AND METHODS
Cell cultures. IB3-1 human cystic fibrosis bronchial cells (JHU-52), HEp-2 human nasopharyngeal carcinoma cells (CCL-23), and A549 human pneumocyte type II carcinoma cells (CCL-185) were obtained from the American Type Culture Collection (ATCC, Manassas, VA). Stocks of cellular suspensions were stored at -180°C in liquid nitrogen. Cells in 24-or 96-well microtiter plates (Costar, Cambridge, MA) were cultured in a CO 2 incubator to confluence at 37°C in Iscove's Modified Dulbecco's Medium (IMDM, Invitrogen, Carlsbad, CA) containing 5% FCS (Hyclone Laboratories, Logan, UT) and gentamicin, 0.01 mg/mL (Invitrogen). Cells were used for experiments between 10 and 25 passages.
Bacteria and labeling. Two mucoid (Pa01 and Pa02) and two nonmucoid (Pa03 and Pa04) clinical P. aeruginosa strains were collected from different CF patients. Two other strains were obtained from ATCC, 39342 (mucoid) and 15692 (nonmucoid). Bacteria were stored in microbanks (Pro-Lab Diagnostics, Austin, TX) at -70°C. Before testing, bacteria were grown on blood agar plates (Trypticase Soy agar with 5% sheep blood, BD Biosciences, San Diego, CA) at 37°C, inoculated in Todd-Hewitt broth (Difco, Detroit, MI) supplemented with 0.5% yeast extract and grown shaken overnight at 37°C .
Bacteria were harvested by centrifugation at 3270 ϫ g. Pelleted bacteria were washed three times with PBS (Cambrex, Verviers, Belgium) and pelleted by centrifugation at 9300 ϫ g for 5 min. For cytometric experiments, bacteria were suspended in 0.1 M sodium carbonate buffer pH 9.0 and adjusted in a spectrophotometer to a concentration of 10 9 bacteria/mL (OD 660 nm ϭ 1.0). The bacteria were freshly labeled with a saturated FITC solution (10 mg/mL DMSO; Merck, Darmstadt, Germany), to a final concentration of 0.5 mg/mL, and incubated for 1 h at 4°C. Efficiency of FITC-coupling as measured in the FACS varied between 76 and 92% labeled bacteria, depending on the bacterial strain. After washing three times with PBS, bacteria were suspended in PBS 2ϩ /BSA 2.5% (Ca 2ϩ 0.15 mM, Mg 2ϩ 0.5 mM enriched with 2.5% BSA (Instruchemie, Hilversum, Netherlands)) to a final concentration of 2.0 ϫ 10 8 CFU/mL (OD 660 nm ϭ 0.25) for direct use, or 4.0 ϫ 10 8 CFU/mL (OD 660 nm ϭ 0.5) for simultaneous addition with RSV. Viral stocks. RSV serotype A (ATCC VR 1302) was grown on HEp-2 monolayers as described previously (15) . Aliquots containing 3.0 ϫ 10 6 PFU/mL were stored at -180°C in liquid nitrogen.
Adherence assay. Adherence experiments were performed as described previously (15) . For RSV infection experiments, monolayers were grown to confluence in 3-4 d; for experiments with simultaneous addition of RSV and P. aeruginosa, including heparin blocking and filtration, monolayers were grown to confluence in 2 d. Medium was removed from the cellular monolayers and 50 L of FITC-labeled bacteria were added. After centrifugation at 160 ϫ g (IEC Centra 3C; IEC, Needham Heights, MA) for 10 min, the plates were incubated at room temperature for 30 min. Total fluorescence (TF) was measured by a fluorescence multi-well plate reader (CytoFluor II; PerSeptive Biosystems, Framingham, MA), with excitation at 485 nm and emission at 530 nm, three readings per well. Subsequently, wells were washed four times with PBS 2ϩ to remove nonadhering P. aeruginosa and after addition of 50 L PBS 2ϩ measured again to determine the fluorescence of adhering bacteria (adherence fluorescence ϭ AF). The final adherence was calculated as adherence ϭ AF/TF ϫ 100 (%).
Viral infection of monolayers. RSV infection of IB3-1, HEp-2, and A549 monolayers was induced as described previously (15) . Cells and serial dilutions (log 3.0 -4.8) of 50 L of an RSV suspension or IMDM as a control were incubated in 96-well microtiter plates at 37°C in a CO 2 incubator. Cytopathological effect (CPE) and percentage of remaining monolayer for the different RSV dilutions were scored under light microscope after each adherence assay.
Binding of RSV to P. aeruginosa. Equal volumes of nonlabeled bacteria (4.0 ϫ 10 8 CFU/mL) and RSV suspension (3.0 ϫ 10 6 PFU/mL and 5.0 ϫ 10 7 PFU/mL, respectively) or PBS/BSA 0.5% as control were co-incubated for 30 min at 37°C in an incubator. After washing and centrifugation twice for 5 min at 9300 ϫ g, 25 L of FITC-labeled MAb against RSV-glycoprotein F (Imagen Kit for RSV, Glostrop, Denmark) was added and incubated for 30 min at 4°C, followed by two washes and suspension in PBS. Fluorescence of 10,000 bacteria was analyzed in a FACScan flow cytometer, expressed as percentage positive bacteria. Simultaneous addition of RSV and P. aeruginosa. Equal volumes of FITC-labeled bacteria (4.0 ϫ 10 8 CFU/mL) and RSV suspension (3.0 ϫ 10 6 PFU/mL) or PBS/BSA 0.5% as control were co-incubated for 30 min at 37°C to form a complex. This mixture (50 L) was added to a 2-d confluent and non-RSV-infected monolayer in a 96-well microtiter plate. These were incubated at room temperature for 30 min after centrifugation at 160 ϫ g for 10 min. Adherence was measured as described above. To study the effect of heparin, a solution of 100 IE/mL sodium heparin was added to the monolayers before adding the bacteria. Heparin-treated monolayers were incubated for 30 min at 37°C in a CO 2 incubator. Then, the heparin solution was removed, bacteria were added, and adherence was measured as described above. Filtration and Purification of RSV suspension. RSV suspension as originally cultured was spun through a 100-kD nitrocellulose filter (Microcon 100 kD filter; Millipore Corporation, Bedford, MA) and the filtrate without RSV virions was used to repeat the simultaneous addition experiments. Purified RSV was prepared by polyethylene glycol (PEG) precipitation.
Scanning electron microscopy. RSV-infected and noninfected HEp-2 cells were grown to confluent monolayers on fibrinogen-coated glass cover slips in 24-well microtiter plates. We added 50 L unlabeled P. aeruginosa (Pa01) ϭ 2.0 ϫ 10 8 bacteria/mL (OD 660 nm ϭ 0.25) to the infected and control monolayers, or co-incubated P. aeruginosa and RSV suspension to the noninfected monolayers, and incubated for 30 min after centrifugation (10 min at 160 ϫ g). Plates were washed four times with PBS and fixated during 10 min at room temperature with glutaraldehyde 2% (Merck) in 0.1 M phosphate buffer, pH 7.4. Monolayers were dehydrated stepwise with ethanol 80% for 10 min at room temperature, followed by ethanol 99.9% for 10 min at room temperature. Then, hexamethyldisilazane, 15 L (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) was added for 10 min to each specimen. Samples were glued on a specimen mount with carbon-based glue (CCCadhesive, Electron Microscopy Sciences, Hatfield, PA) after drying. Samples were titanium-sputtered (Sputter Coater 208HR, Cressington Scientific Instruments Ltd., Watford, U.K.) and examined with a scanning electron microscope FEI XL30SFEG (Royal Philips Electronics, Eindhoven, The Netherlands).
Statistics. Cytometric fluorescence adherence experiments were performed three times, and in each experiment seven wells per same treatment were used. Results are expressed as mean Ϯ SEM. Data of RSV-P. aeruginosa coupling and RSV filtration experiments are from one of two representative experiments and expressed as mean Ϯ SD. Each of these experiments was performed in duplicate. All comparisons were done by t test with statistical program SPSS for Windows 12.0.2 (SPSS Inc., Chicago, IL). A value of p Ͻ 0.05 was considered significant for these comparisons.
RESULTS
Effect of RSV infection on P. aeruginosa adherence. The in vitro adherence of the different P. aeruginosa strains to human respiratory epithelial cells with and without RSV infection was tested to evaluate the effect of virus infection on pseudomonal adherence. Adherence of P. aeruginosa to noninfected respiratory epithelial cells varied for each strain and cell type. Maximum adherence to IB3-1 cells was found at an RSV infecting dose of log 3.35 on the third day of RSV infection, to HEp-2 and A549 cells on the fourth day at RSV infecting doses of log 3.70 and 3.18, respectively (data not shown). This RSV infection of respiratory epithelial cells consistently resulted in an increased maximum adherence of all P. aeruginosa strains after 30 min incubation to these cells (IB3-1 d 3, HEp-2, and A549 d 4), compared with noninfected epithelial cells (Fig. 1 ). It varied between the different strains and cell types from 1.2-to 8.2-fold, compared with no RSV. This maximum increased adherence of each Pseudomonas strain after RSV infection, compared with no RSV, was significant for all strains and all cell types (p Ͻ 0.05), except for strains Pa01 and Pa04 on A549 cells. RSV concentrations above log 3.35 for IB3-1, log 3.7 for HEp-2, and log 3.18 for A549 (Fig. 2 ) resulted in loss of monolayers due to cytopathological effect on d 3 (IB3-1) and d 4 (HEp-2 and A549), with a decrease of total measured Pseudomonas adherence. In addition, we found the enhanced adherence of P. aeruginosa to be RSV dose dependent in all three cell types (Fig. 2) , on d 3 (IB3-1) and d 4 (HEp-2 and A549), respectively.
Binding of RSV to P. aeruginosa. We hypothesized that the increased pseudomonal adherence could be due to binding to virus-induced up-regulated cellular membrane proteins or to viral glycoproteins expressed on the cell membrane. We first tested whether RSV and Pseudomonas bacteria can bind directly to each other. Pseudomonal suspension was compared with a suspension of RSV and P. aeruginosa. RSV with a dose of 3.0 ϫ 10 6 PFU/mL bound directly to all P. aeruginosa strains, varying from 0.34% to 1.67% (mean, 0.94 Ϯ 0.58 SD) RSV glycoprotein F-positive bacteria. In addition, an increased RSV dose of 5.0 ϫ 10 7 PFU/mL resulted in a dosedependent and increased binding of RSV and P. aeruginosa. It varied from 4.7% to 9.97%, mean, 6.58 Ϯ 2.09 SD (data not shown).
Effect of simultaneous addition of RSV and P. aeruginosa. To further explore the role of RSV in increased pseudomonal adherence, we compared the adherence of P. aeruginosa alone with P. aeruginosa co-incubated with RSV to noninfected epithelial cells. Adherence of P. aeruginosa alone to noninfected respiratory epithelial cells grown to confluence in 2 d varied for each strain and cell type. The co-incubated RSV-P. aeruginosa complex consistently led to an increased adherence of P. aeruginosa to the respiratory epithelial cells, compared with P. aeruginosa alone (Fig. 3) . This increased adherence varied between the different strains and cell types from 1.7-to 16.1-fold and was significant for all strains and in all cell types (p Ͻ 0.05).
RSV-ENHANCED PSEUDOMONAL BINDING
Effect of RSV filtrate and purified RSV suspension. The increased adherence of P. aeruginosa to noninfected epithelial cells when added simultaneously with RSV could be due to RSV acting as a coupling agent between bacteria and epithelial cells or alternatively due to inflammatory mediators in the RSV suspension inducing up-regulation of cellular membrane proteins involved in pseudomonal adherence. To investigate these two possibilities, we incubated P. aeruginosa with either unfiltered RSV suspension or RSV filtrate. The RSV filtrate contained all components, including inflammatory mediators from the original RSV culture, except the RSV virions by spinning through a filter. Similar adherence experiments were repeated with a purified RSV suspension without inflammatory mediators. Figure 4 shows that both original and purified RSV suspensions yielded similarly increased pseudomonal adherence of 30.7% Ϯ 0.8 SD and 33.0% Ϯ 1.12 SD, respectively. The filtrate induced no increase at all (3.8% Ϯ 0.5 SD), compared with no RSV (5.6% Ϯ 0.4 SD).
Effect of glycoprotein G blocking by heparin on binding.
RSV binding to host cells is mediated by glycoprotein G, which can be specifically blocked by heparin. To investigate whether the enhanced binding of the co-incubated RSV-P. aeruginosa complex to noninfected epithelial cells was mediated by RSV glycoprotein G, we pretreated cells with heparin. Heparin itself had no effect on the adherence of P. aeruginosa to noninfected cells (data not shown). Figure 5 shows that pretreatment of the noninfected cells with heparin led to nearly complete blocking of the enhanced adherence of co-incubated RSV-P. aeruginosa complex, which was significant (p Ͻ 0.05) for all tested strains. This blocking was heparin dose dependent and similar blocking of enhanced adherence with heparin was found in HEp-2 and A549 cells (data not shown).
Visualization by scanning electron microscopy. Because adherence measured by fluorescence of FITC-labeled bacteria is an indirect and possibly rather insensitive method, we visualized the effect of previous RSV infection and simulta- neous addition of RSV with P. aeruginosa on adherence by performing scanning electron microscopy studies. Incubation of P. aeruginosa without RSV showed only a few bacteria adhering to epithelial cells (Fig. 6B) . A major increase in adherence was observed when P. aeruginosa was added to RSV infected epithelial cells, adhering mainly to syncytia induced by the RSV infection (Fig. 6,C and D) . In contrast, a more even distribution was observed when P. aeruginosa and RSV were added simultaneously to uninfected epithelial cells, again considerably increased compared with adherence in the absence of RSV (Fig. 6,E and F ).
DISCUSSION
Our study shows that both RSV infection of human respiratory epithelial cells and simultaneous addition of coincubated RSV and P. aeruginosa to noninfected epithelial cells strongly enhance the adherence of P. aeruginosa to these cells. This was shown with both laboratory and clinical bacterial strains and in multiple cell types. In addition, we observed direct binding of RSV to P. aeruginosa, suggesting that RSV possibly acts as a coupling agent between P. aeruginosa and epithelial cells. Specific blocking with heparin eliminates the increased adherence of P. aeruginosa, suggesting that this 401 coupling of P. aeruginosa to the cells is mediated through RSV glycoprotein G. Scanning electron microscopy shows a striking difference in pattern of pseudomonal adherence to RSV-infected epithelial cells compared with simultaneous addition of co-incubated RSV and P. aeruginosa to noninfected cells, suggesting that different mechanisms of increased adherence are possible.
There are several potential mechanisms to explain our findings of RSV-induced enhancement of pseudomonal adherence to respiratory epithelial cells. Bacteria can bind to virusinduced and up-regulated cellular membrane proteins, and to induced viral glycoproteins like glycoprotein F, G, and neuraminidase on the surface of infected cells (16) . We show in addition that RSV possibly acts as a coupling agent for pseudomonal binding to respiratory epithelial cells.
Our data offer several arguments to suggest such a direct coupling mechanism. Simultaneous addition of co-incubated RSV and P. aeruginosa results in increased binding of bacteria to RSV-uninfected monolayers. During the simultaneous addition of RSV and P. aeruginosa, expression or upregulation of cellular or viral proteins on the epithelial cell membranes, or up-regulation of inflammatory mediators is less likely because of the relatively short time interval between adding of co-incubated bacteria and virions and the assessment of adherence. In addition, filtration experiments show that the enhancing effect of RSV on Pseudomonas adherence is due only to RSV virions and not to any other products in the RSV suspension, such as inflammatory mediators produced during RSV culture. We demonstrate furthermore a direct binding between RSV and P. aeruginosa in a dose-dependent manner.
We suggest that this coupling mechanism can be mediated through binding of P. aeruginosa to glycoprotein G, known to be expressed on the surface of RSV (16) . Pretreatment of respiratory cells with heparin, which interacts with glycoprotein G (17) , gives a nearly complete blocking of the enhanced adherence of co-incubated RSV-P. aeruginosa complex. Nonspecific blocking by heparin, e.g. inhibition of inflammatory mediators, is less probable in view of the short time interval.
Scanning electron microscopy confirms the findings of the fluorescence assays by showing only little adherence of P. aeruginosa to respiratory epithelial cells in the absence of RSV, and a strongly enhanced pseudomonal adherence in the presence of the virus. It shows furthermore a striking difference in pattern of bacterial adherence. While P. aeruginosa mainly adheres to syncytia after RSV infection of epithelial cells, the strongly increased adherence is more evenly distributed with the simultaneous addition of RSV and P. aeruginosa to noninfected cells. This could suggest that the RSV-P. aeruginosa complex can bind to any epithelial cell, whereas adherence of P. aeruginosa alone is enhanced by binding, presumably to virus-induced glycoproteins expressed on syncytia after RSV infection.
The present study is the first to report that RSV infection can increase the adherence of P. aeruginosa to respiratory epithelial cells in vitro. This corresponds to earlier clinical observations that initial Pseudomonas colonization might be facilitated by respiratory viral infections, especially by RSV (12) (13) (14) . In addition, a viral infection can be associated with a rise in antipseudomonal antibodies in CF patients with intermittent or chronic pseudomonal colonization, especially in case of RSV infection (14) . These findings are furthermore consistent with several studies that demonstrate enhanced adherence of bacteria, like Haemophilus influenzae and Staphylococcus aureus, to epithelial cells after viral infection in vitro (9, 18, 19) and in vivo (20, 21) . However, there are only few experimental data about synergism between viruses and P. aeruginosa in inducing infections. In a study by Ramphal et al. (26) , P. aeruginosa only adheres to murine tracheas when injured by influenza infection. Seki et al. (27) showed influenza infection to play an important role in inducing fatal pneumococcal pneumonia in chronic P. aeruginosa-infected mice. Recently, Stark et al. (24) found a decreased clearance of P. aeruginosa from the lungs after a RSV infection in non-CF mice. Although P. aeruginosa is the most important bacterial pathogen in CF, the synergism between RSV and P. aeruginosa in infecting respiratory epithelial cells seemed not to be CF-specific in the present study. We observed no consistent differences between IB3-1 (CF) cells and HEp-2 or A549 (non-CF) cells, however, not having used isogenic cell lines.
There are limitations of our study. Our in vitro data do not necessarily reflect in vivo situations, and the role of other Figure 6 . Visualization of pseudomonal adherence to HEp-2 cells by scanning electron microscopy (ϫ4000/7500) shows noninfected cells without P. aeruginosa (A, ϫ4000), noninfected cells with little adherence (arrows) of P. aeruginosa (B, ϫ4000), large amounts of P. aeruginosa mainly adhering to syncytia (arrows) of RSV infected cells (C, ϫ4000; D, ϫ7500) and large amounts of P. aeruginosa adhering more evenly after simultaneous addition of co-incubated RSV and P. aeruginosa to noninfected cells (E, ϫ4000; F, ϫ7500).
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viruses on adherence of P. aeruginosa still has to be determined. However, we used multiple cell types and both clinical and laboratory bacterial strains with consistent findings of enhanced adherence. Adherence of P. aeruginosa without RSV varies in similar cell types between the different experiments, but monolayers were, depending on the experiment, grown to confluence in 2 or 3-4 d, respectively. Induction of specific bacterial factors might be another mechanism influencing adherence, but was outside the scope of the present study.
Our findings of RSV-induced enhancement of pseudomonal adherence in general might be interesting in a clinical perspective. P. aeruginosa is a selective and important pathogen in CF. Recent data in CF mice underline the relevance of RSV infections in pulmonary morbidity in CF (25) . It might be suggested that viral infections like RSV facilitate bacterial colonization, e.g. with P. aeruginosa. Further knowledge about synergism between viruses and bacteria in CF lung disease might result in new therapeutic strategies to improve prognosis of patients with CF. If our in vitro results can be confirmed in vivo, the suggestion that viral infections can play a role in bacterial colonization and pulmonary CF exacerbations might implicate adaptation of current therapeutic strategies and development of new options. For example, nebulization with heparin might possibly reduce the risk of bacterial colonization and infection in case of an RSV infection. Moreover, prevention of viral infections will be emphasized, e.g. by active or passive immunization. Viral inhibitors might be used in an early phase of a viral infection, antibiotic treatment, or prophylaxis during a viral infection, and development of other specific viral-bacterial interaction blockers might provide interesting options.
In summary, this is the first report that RSV infection of respiratory epithelial cells and simultaneous addition of RSV and P. aeruginosa to noninfected epithelial cells both strongly enhance the in vitro adherence of P. aeruginosa. In this process, RSV possibly acts as a coupling agent. Heparin seems able to block RSV and to eliminate this enhanced bacterial adherence. It confirms the suggestion that viral infections possibly play a role in bacterial colonization and pulmonary CF exacerbations. If these results can be confirmed in vivo, it could have important implications on treatment of CF pulmonary disease.
